Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer

Human Molecular Genetics

Volumn 21, Issue 14, 2012, Pages 3112-3127

  Fletcher, Claire E ^a   Dart, D Alwyn ^a   Sita lumsden, Ailsa ^a   Cheng, Helen ^b   Rennie, Paul S ^b   Bevan, Charlotte L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b VANCOUVER PROSTATE CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; DACTINOMYCIN; DOXORUBICIN; MESSENGER RNA; MICRORNA; MICRORNA 23A; MICRORNA 24; MICRORNA 27A; PROHIBITIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING;

ANDROGENS; BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84863992937     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds139     Document Type: Article

References (57)

1. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics, 2010. CA: Cancer J. Clin., 60, 277-300.
2. Koivisto, P., Kolmer, M., Visakorpi, T. and Kallioniemi, O. (1998) Androgen receptor gene and hormonal therapy failure of prostate cancer. Am. J. Pathol., 152, 1-9.
3. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Schulman, I.G., Juguilon, H., Montminy, M. and Evans, R.M. (1996) Role of CBP/ P300 in nuclear receptor signalling. Nature, 383, 99-103.
4. Li, J., O'Malley, B.W. and Wong, J. (2000) p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin. Mol. Cell Biol., 20, 2031-2042.
5. Spencer, T.E., Jenster, G., Burcin, M.M., Allis, C.D., Zhou, J., Mizzen, C.A., McKenna, N.J., Onate, S.A., Tsai, S.Y., Tsai, M.-J. et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
6. Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J.C., Li, H. and Chen, J.D. (2003) Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem., 278, 5052-5061.
7. Hodgson, M.C., Astapova, I., Cheng, S., Lee, L.J., Verhoeven, M.C., Choi, E., Balk, S.P. and Hollenberg, A.N. (2005) The androgen receptor recruits nuclear receptor corepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists. J. Biol. Chem., 280, 6511-6519.
8. Shenouda, S. and Alahari, S. (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metast. Rev., 28, 369-378.
9. Volinia, S., Calin, G.A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261.
10. Pang, Y., Young, C.Y.F. and Yuan, H. (2010) MicroRNAs and prostate cancer. Acta Biochem. Biophys. Sin., 42, 363-369.
11. Porkka, K.P., Pfeiffer, M.J., Waltering, K.K., Vessella, R.L., Tammela, T.L.J. and Visakorpi, T. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res., 67, 6130-6135.
12. Gamble, S.C., Chotai, D., Odontiadis, M., Dart, D.A., Brooke, G.N., Powell, S.M., Reebye, V., Varela-Carver, A., Kawano, Y., Waxman, J. et al. (2006) Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene, 26, 1757-1768.
13. Gamble, S.C., Odontiadis, M., Waxman, J., Westbrook, J.A., Dunn, M.J., Wait, R., Lam, E.W.F. and Bevan, C.L. (2004) Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene, 23, 2996-3004.
14. Dart, D.A., Spencer-Dene, B., Gamble, S.C., Waxman, J. and Bevan, C.L. (2009) Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours. Endocr. Relat. Cancer, 16, 1157-1169.
15. Coates, P.J., Jamieson, D.J., Smart, K., Prescott, A.R. and Hall, P.A. (1997) The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr. Biol., 7, 607-610.
16. Steglich, G., Neupert, W. and Langer, T. (1999) Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol. Cell Biol., 19, 3435-3442.
17. Mishra, S., Murphy, L.C. and Murphy, L.J. (2006) The Prohibitins: emerging roles in diverse functions. J. Cell Mol. Med., 10, 353-363.
18. Wang, S., Fusaro, G., Padmanabhan, J. and Chellappan, S. (2002) Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene, 21, 8388-8396.
19. Terashima, M., Kim, K., Adachi, T., Nielsen, P., Reth, M., Kohler, G. and Lamers, M. (1994) The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J., 13, 3782-3792.
20. Fusaro, G., Dasgupta, P., Rastogi, S., Joshi, B. and Chellappan, S. (2003) Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem., 278, 47853-47861.
21. Rajalingam, K., Wunder, C., Brinkmann, V., Churin, Y., Hekman, M., Sievers, C., Rapp, U.R. and Rudel, T. (2005) Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol., 7, 837-843.
22. Zhu, B., Zhai, J., Zhu, H. and Kyprianou, N. (2009) Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of smad-dependent and-independent signaling. Prostate, 70, 17-26.
23. Liu, T., Tang, H., Lang, Y., Liu, M. and Li, X. (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett., 273, 233-242.
24. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
25. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
26. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA, 101, 2999-3004.
27. Cimmino, A., Calin, G.A., Fabbri, M., Iorio, M.V., Ferracin, M., Shimizu, M., Wojcik, S.E., Aqeilan, R.I., Zupo, S., Dono, M. et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA, 102, 13944-13949.
28. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D. and Slack, F.J. (2005) RAS is regulated by the let-7 MicroRNA family. Cell, 120, 635-647.
29. Catto, J.W.F., Alcaraz, A., Bjartell, A.S., De Vere White, R., Evans, C.P., Fussel, S., Hamdy, F.C., Kallioniemi, O., Mengual, L., Schlomm, T. et al. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol., 59, 671-681.
30. Sevli, S., Uzumcu, A., Solak, M., Ittmann, M. and Ozen, M. (2010) The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis., 13, 208-217.
31. Ozen, M., Creighton, C.J., Ozdemir, M. and Ittmann, M. (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene, 27, 1788-1793.
32. Prueitt, R.L., Yi, M., Hudson, R.S., Wallace, T.A., Howe, T.M., Yfantis, H.G., Lee, D.H., Stephens, R.M., Liu, C.-G., Calin, G.A. et al. (2008) Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate, 68, 1152-1164.
33. Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S.H. and Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 23, 4051-4060.
34. Chhabra, R., Dubey, R. and Saini, N. (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol. Cancer, 9, 232.
35. Saini, H.K., Griffiths-Jones, S. and Enright, A.J. (2007) Genomic analysis of human microRNA transcripts. Proc. Natl Acad. Sci. USA, 104, 17719-17724.
36. Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M.B., Wang, Y., Qian, Z., Jin, J., Zhang, Y. et al. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl Acad. Sci. USA, 104, 19971-19976.
37. Saumet, A., Vetter, G., Bouttier, M., Portales-Casamar, E., Wasserman, W.W., Maurin, T., Mari, B., Barbry, P., Vallar, L., Friederich, E. et al. (2009) Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood, 113, 412-421.
38. Mertens-Talcott, S.U., Chintharlapalli, S., Li, X. and Safe, S. (2007) The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res., 67, 11001-11011.
39. Xi, Y., Formentini, A., Chien, M., Weir, D.B., Russo, J.J., Ju, J., Kornmann, M. and Ju, J. (2007) Prognostic values of microRNAs in colorectal cancer. Biomark. Insights, 2006, 113.
40. Huang, S., He, X., Ding, J., Liang, L., Zhao, Y., Zhang, Z., Yao, X., Pan, Z., Zhang, P., Li, J. et al. (2008) Upregulation of miR-23a27a24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer, 123, 972-978.
41. Nam, E.J., Yoon, H., Kim, S.W., Kim, H., Kim, Y.T., Kim, J.H., Kim, J.W. and Kim, S. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res., 14, 2690-2695.
42. Chhabra, R., Adlakha, Y.K., Hariharan, M., Scaria, V. and Saini, N. (2009) Upregulation of miR-23a~27a~24-2 cluster induces caspase-dependent and-independent apoptosis in human embryonic kidney cells. PLoS ONE, 4, e5848.
43. Buck, A.H., Perot, J., Chisholm, M.A., Kumar, D.S., Tuddenham, L., Cognat, V., Marcinowski, L., Dalken, L. and Pfeffer, S. (2010) Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA, 16, 307-315.
44. Cheng, H., Snoek, R., Ghaidi, F., Cox, M.E. and Rennie, P.S. (2006) Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res., 66, 10613-10620.
45. Peterziel, H., Mink, S., Schonert, A., Becker, M., Klocker, H. and Cato, A. (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene, 18, 6322-6329.
46. Lee, Y. and Kim, V.N. (2007) In vitro and in vivo assays for the activity of Drosha complex. Methods Enzymol., 427, 89-106.
47. Zeng, Y. and Cullen, B.R. (2003) Sequence requirements for micro RNA processing and function in human cells. RNA, 9, 112-123.
48. Zeng, Y., Yi, R. and Cullen, B.R. (2005) Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J., 24, 138-148.
49. Jupe, E., Liu, X., Kiehlbauch, J., McClung, J. and Dell'Orco, R. (1996) Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations. Cell Growth Differ., 7, 871-878.
50. Sato, T., Saito, H., Swensen, J., Olifant, A., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., Miki, Y. et al. (1992) The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52, 1643-1646.
51. Jakubowska, A., Gronwald, J., Górski, B., Huzarski, T., Byrski, T., Benner, A., Lubiński, J., Scott, R.J. and Hamann, U. (2007) The 3' untranslated region C.T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res. Treat., 104, 67-74.
52. Li, X., Mertens-Talcott, S.U., Zhang, S., Kim, K., Ball, J. and Safe, S. (2010) MicroRNA-27a indirectly regulates estrogen receptor a expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology, 151, 2462-2473.
53. Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J.W., Carrasco, D.R. et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 128, 309-323.
54. Fu, Z. and Tindall, D.J. (2008) FOXOs, cancer and regulation of apoptosis. Oncogene, 27, 2312-2319.
55. Varallyay, E., Burgyan, J. and Havelda, Z. (2008) MicroRNA detection by northern blotting using locked nucleic acid probes. Nat. Protocols, 3, 190-196.
56. Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol., 7, 2745-2752.
57. Brooke, G.N., Culley, R.L., Dart, D.A., Mann, D.J., Gaughan, L., McCracken, S.R., Robson, C.N., Spencer-Dene, B., Gamble, S.C., Powell, S.M. et al. (2011) FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. Cancer Res., 71, 914-924.